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Abstract

The value of patient education has been widely documented in various patient
populations. The main focus of this study is to evaluate the timing of patient education in
correlation with the time since diagnosis. The goal of this study is to make recommendations for
the optimal time in which patient education should be delivered following a diagnosis of
Multiple Sclerosis (MS). This study evaluates self-advocacy using the Patient Self-Advocacy
Scale (PSAS) which was completed pre and post educational programs. This data, combined
with demographic data was analyzed for any relationships. Although no statistically significant
findings were established, many important trends in data were noted which support the need for
patient education.
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CHAPTER 1: INTRODUCTION
Introduction and Background
Recent research has shown the benefits of a multidisciplinary approach to the
treatment of Multiple Sclerosis (MS). (Burks, 2000; Halper, 2010; Namey, 2010). This
includes many new treatment options including disease-modifying medications.
However, many patients live in areas with limited access to care, are not provided with
appropriate information to effectively self-advocate in disease management. There is no
current standard regarding the optimal amount and timing of disease information
provided to patients after receiving a diagnosis of Multiple Sclerosis.
Treatment of MS includes medication management and monitoring of disease
progression by a physician or nurse practitioner. There is also a significant amount of
research supporting the benefits of a multidisciplinary approach to MS management,
including nursing, rehabilitation experts, social workers, nutritionists and mental health
practitioners, and others. Due to the wide range of clinicians involved in care, there is
potential for education to be completed in various settings and depending on the
healthcare system, there may be little to no communication between providers. The goal
of this research is to standardize the timing of education provided to patients newly
diagnosed with MS to maximize their ability to act as their own advocates for healthcare
needs.
One of the challenges of caring for people with MS in less populated areas is the
lack of access to healthcare specialists. In some instances, a general neurologist or
physical therapist may provide patient care instead of providers with specialized training
in the management of patients with MS. There is a growing trend of larger healthcare
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systems to guide patients towards specialists to optimize care. In these larger systems,
there are often resources available to support medical care through support groups,
exercise programs, educational programs and access to a wider variety of medical
professionals. One strategy for supporting the medical treatment of MS is to offer
educational programs provided by a variety of clinical specialists.
Many larger healthcare systems have access to expert clinicians of varying
specialties of care to provide patient education. A common model is for routine
educational programs to be offered for newly diagnosed patients with MS. Depending on
when patients are diagnosed and/or their availability to attend, there is variable timing for
when these classes might take place. In one healthcare system, a four-hour educational
program titled “MS 101” is offered quarterly. The neurologist encourages patients to
attend the next available course following a definitive diagnosis of MS. However,
depending on the timing and patient availability, several months or years may pass before
the patient might attend this program. In other cases, patients may attend a session the
first week they are diagnosed, when the news is still very novel.
A current model for this educational program includes information from social
workers, nurses and mental health professionals. The medical team is introduced,
resources available to patients are presented and discussions about disease progression,
including the disability process and mobility options are addressed. Depending on the
patients’ attitude, this information may be overwhelming or depressing, or patients may
feel that some of this information may negatively impact their future outlook. Other
individuals may receive this information and process it all, and may find most of it
relevant to their individual needs.
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Statement of the Problem
The problems related to education in patients with Multiple Sclerosis are multifactorial. The first challenge is the potential for patients to be overwhelmed with new
information shortly after being diagnosed with this progressive neurologic condition.
The second problem is that if patients are not educated in a timely manner, they may have
low self-efficacy, autonomy and ability to advocate for personal needs. This may lead to
limited ability to participate in treatment decisions based on those needs. In modern day
healthcare systems, there is increased need for patients to be active participants with
health care providers in decision making related to the care of their condition. Poor
timing of education can potentially impact a patient’s self-efficacy as well. If education
is not quickly received patients may be ineffective in self advocacy. Conversely,
providing too much education too quickly may overwhelm patients with information.
Purpose of the Study
The purpose of this study is to determine the appropriate amount and timing of
education to patients that are newly diagnosed with Multiple Sclerosis to maximize selfefficacy. The goal is to determine patient cognitive load after receiving a diagnosis of a
progressive neurological condition and tailor educational programs to best meet patient
needs. An additional purpose is to identify the patient’s perceived ability to act as their
own advocate following diagnoses of a progressive neurologic condition.
Research Questions/Hypotheses
Research Question 1: How does the timing of patient education affect self-advocacy in
patients with MS?
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Research Question 2: How does the amount of information provided to patients with MS
impact their self-advocacy?
Research Question 3: What demographic information correlates with self-advocacy?
Research Question 4:What are the optimal time frames in which diagnosis education
should occur?
Research Question 5: How much information can patients with a progressive neurologic
condition absorb in the acute phase of diagnosis?
Hypotheses
H1 (Null): There is no relationship between the timing of education and patient selfadvocacy.
H1 (Alternate): There is a relationship between the timing of education and patient selfadvocacy.
H2 (Null): The amount of education has no impact on self-advocacy.
H2 (Alternate): The amount of education provided negatively impacts self-advocacy.
H3 (Null): There is no correlation between demographics and patient reported selfadvocacy.
H 3 (Alternate): There is a correlation between demographics and patient reported selfadvocacy.
H4 (Null): There is no correlation between timing of patient education and selfadvocacy.
H4 (Alternate): There is a correlation between the timing of patient education delivery
and self-advocacy.
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H5 (Null): There is no relationship between the amount of information provided to
patients and reported self-advocacy.
H5 (Alternate): There is a relationship between the amount of information provided to
patients and reported self-advocacy.
My hypothesis is when provided with four hours of education close to the time of
diagnosis (less than 2 months), patient retention and self-efficacy will be poor. I also
believe demographic data contributes to the self-efficacy of patients with Multiple
Sclerosis.
Significance of the Study
The goal of this study is to determine how much education should be provided to
newly diagnosed patients with Multiple Sclerosis and when that information should be
provided. Clinical observation and the literature have shown that there is a wide variety
of educational models for individuals with MS. Patients are educated at varying points
after receiving the diagnosis and this may impact the ability to effectively self-advocate.
Self-advocacy has been well studied in cancer, mental illness and AIDS patients and has
been shown to positively affect the quality of care patients receive. (Brashers et. al,
1999; Jonikas et. al, 2013; National Mental Health Clearinghouse). This study should
offer guidelines on the optimal amount and timing to provide the information to patients
about MS and treatment options. By improving these factors, patients should more
effectively advocate for themselves, obtain better care and outcomes with improved
quality of life. There is potential to standardize this information throughout MS centers
to better educate and optimally treat these patients.
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Research studies have shown that patient education programs provided in acute
care settings lead to decreased readmission rates and decreased follow-up visits to
emergency rooms, suggesting a decrease in overall healthcare costs. (Jack et. al, 2009).
Assumptions & Limitations
In this research, it is assumed that patients with Multiple Sclerosis who choose to
attend educational program after a diagnosis are motivated to better advocate and to
participate in decision making related to treatment. It is assumed that participants in the
MS 101 courses will provide accurate demographic information and healthcare
professionals that lead the course are sufficiently trained and considered to be experts in
the area of Multiple Sclerosis.
There are limitations to this study, including patient willingness to participate in
MS 101. The dates, times, and locations of the course, as well as personal motivation
may affect patient participation. Three MS 101 courses will be used for analysis and will
take place on different days and different times of day.

Additional limitations may be

accurate reporting from participants completing pre and posttest information and the
analysis of education programs is from three courses provided only at Norton Healthcare
in Louisville, KY.
Nature/Organization of the Study
Patients who choose to participate in the MS 101 courses offered in the second
half of 2016 will be asked to provide demographic data and the date of MS diagnosis.
They will complete a pre-course Patient Self-Advocacy Scale (PSAS). The study will
categorize patients based on elapsed time since diagnosis and compare self-efficacy
scores before and after the educational program, MS 101. An ANOVA comparison will
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compare patients in various timeframes since diagnosis and scores on their self-efficacy
outcomes.
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CHAPTER 2 – LITERATURE REVIEW
Introduction
Multiple Sclerosis (MS) is a chronic and progressive disease affecting the central
nervous system. As an immune-mediated disorder in which the immune system destroys
myelin, the protective sheath around nerves, MS results in slowed conduction of nerve
signals and manifests itself in a wide variety of clinical presentations. Currently, there
are about 400,000 individuals living with MS in the United States. Typically, the onset
of symptoms occurs between ages 20-40, affects women more than men, and has no
significant impact on life-span. MS symptoms are highly variable from person to person;
common signs and symptoms may include optic neuritis, weakness, paresthesias, pain,
fatigue, cognitive impairments or balance deficits. Optic neuritis is an inflammatory
process of the optic nerve that presents as unilateral eye pain or vision problems, usually
occurring early on in the disease process. Paresthesias are a common initial symptom of
MS, presenting as numbness, tingling or atypical pain throughout the body. The National
MS Society estimates that at least half of all patients with MS will develop cognitive
impairments at some point. There are several possible presentations including
impairments in memory, attention, information processing, decision-making and word
finding. Memory impairments typically affect short-term memory or the ability to recall
things for brief periods of time, while long term memory is generally unaffected.
Impairments in information processing typically affect the ability to interpret information
gathered through verbal, visual or sensory delivery. Currently, there is no specific
diagnostic test for MS, but a diagnosis is generally made by a neurologist’ s interpretation
of magnetic-resonance imaging (MRI) results, lumbar puncture to test for presence of
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oligoclonal bands in the cerebrospinal fluid, and possibly nerve-conduction velocity
testing.
Currently, there is also no cure for MS. Instead the disease is managed through
disease-modifying therapies (DMTs), a class of drugs new to the market in the past two
decades, which are designed to slow disease progression. DMTs and serial imaging are
managed in most cases by a neurologist, but there is significant need for a multidisciplinary approach to care for patients with MS. Ideally, the treatment team should
include the neurologist and neurologic nurse practitioner, a registered nurse (RN) that
specializes in the management of MS, mental health providers, social workers and a
rehabilitation team including physical, occupational and speech therapists. Halper (2010)
defined the importance of an MS nurse to facilitate patient education including
information about the diagnosis, treatments, and access to resources. Gallien et. al.
(2014) has described the value of multidisciplinary care models to treat MS given the
complexity of the disease. This paper discussed the role of neuropsychology including
cognitive and psychological impairments that should be treated in collaboration with
psychiatry, psychology, and speech therapy to comprehensively address the impairments
from both medical and non-medical approaches. A similar model for pain management
was suggested including rehabilitation professionals, nursing, pharmacotherapy, and
medical management.
There are four major classifications of MS according to the National MS Society:
relapsing-remitting, primary progressive, secondary progressive and progressiverelapsing. Relapsing-remitting is the most common form of MS affecting about 85% of
patients and is characterized by periods of active inflammation and demyelination in the
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CNS followed by periods of remission or stability of the disease. Primary progressive
MS is defined as worsening neurologic function from the time of diagnosis with or
without relapses and remissions. This form of MS affects about 15% of patients.
(National MS Society). Secondary progressive MS (SPMS) typically begins as a
relapsing-remitting course and transitions to SPMS when there is progressive worsening
or neurologic decline over time. Patients with SPMS may experience worsening of
neurologic function even during times where there is no active inflammatory process or
demyelination occurring. Progressive-relapsing MS is characterized by a steady decline
in function from the time of diagnosis with occasional periods of relapse and is
considered to be a form of primary progressive MS. (Halper, 2010; National MS
Society).
MS is typically managed with disease-modifying therapies (DMTs) to decrease
the frequency and intensity of exacerbations or active inflammatory processes that result
in demyelination of nerves. Once a neurologist has confirmed a diagnosis of MS, they
select the DMTs that are most appropriate for that patient based on potential side effects
and risks associated with each drug. Routine MRI studies and clinical examinations by a
neurologist are utilized to assess for disease progression including MRI changes
indicating active demyelination or clinical worsening of symptoms or patient
presentation. In the event of MRI changes or clinical progression, a neurologist can
determine if the patient is having a suboptimal response to their DMT and whether the
medication should be altered. Adjunct medical therapies may be indicated for symptom
management including spasticity control, bowel and bladder dysfunction, fatigue, sleep
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disorders or pain. The neurologist also facilitates referral to other healthcare providers
for additional support in management of MS.
The Multiple Sclerosis Association, Multiple Sclerosis Society and local chapters
or centers are a primary source of information and resources for people with MS. These
organizations offer information on a variety of topics related to MS, and often host live
seminars or educational programs related to the disease. Kieseier (2015) discussed the
dynamic nature of MS and the evolving treatments available as disease-modifiers or
adjunctive therapies, stressing the importance of education of patients and healthcare
providers.
Patient Education
The need for lifelong management of progressive neurologic diseases such as MS have been well
Described. (Feicke, 2014, Gallien et. al., 2014; Halper, 2010; Kieseier, 2015; Matti et.al.
2010.) Treatment approaches to MS have changed significantly over the past several
years. (Kiesier, 2015) The past two decades have allowed for development of thirteen
Food and Drug Administration (FDA) approved DMTs as well as improved magneticresonance imaging (MRI) techniques to monitor disease progression. Additionally,
public understanding of the nature and management of progressive neurologic diseases
has increased recently.
Gallien et. al. (2014) described the importance of treatment of individuals with MS being
multimodal and interdisciplinary. This study delineates the importance of a collaborative
team of neurologists, physical therapists, occupational therapists, speech language
pathologists and other healthcare providers in the management and treatment of the
person with MS. However, it may be important to educate patients on the expertise of
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each provider in order to clearly express their needs to the appropriate provider. There
are many studies that highlight the effectiveness of educational programs in management
and compliance of treatment in progressive conditions. (Fraser, 2009; Holman 2004).
Bishop and Frain (2007, 2011) have identified five components of MS-specific selfmanagement abilities. These dimensions include treatment adherence and barriers,
understanding and actively learning about MS, managing one’s health, being an active
participant in decision making, and managing the impact of MS on life. These
components are based on the foundational education that was provided to individuals at
or near the time of diagnosis. Patients must first receive education on MS and various
treatment options available to become active participants in the decision making process.
Furthermore, all of these components are addressed in the MS 101 program to assess the
correlation between MS education and self-efficacy.
Kopke et. al. (2009) studied the relationship between patient autonomy and
management of relapses in MS. In this study, 150 people with relapsing-remitting MS
were provided education about their disease in a structured group format after being
provided with written educational materials prior to attending the course. The
educational information provided data on the option of oral corticosteroid or 3-day high
dose intravenous steroids in the event of an acute relapse. The control group received
educational materials regarding only disease relapse and the use of corticosteroids
therapies. Participants were followed for two years with periodic phone calls to inquire
about relapses. The authors concluded that the structured educational program had a
significant impact on patient decision-making ability and autonomy when it came to the
treatment of acute relapses of their MS. The structured education focused on recognition
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of an actual relapse compared to possible pseudo-relapse and when to contact a physician
for assistance. Patients that received the structured educational information were less
likely to pursue the use of steroids and were more cautious in their use of these drugs.
Patients were followed for two years, and there were no significant differences between
groups for quality of life or disability statues. In this study, structured educational
interventions were associated with improved management of relapses, decreased use of
steroids and overall improved autonomy. (Kopke, 2009). The limitations of this study
include the lack of blinding of outcome evaluators, which potentially could have biased
participant’s decisions. Additionally, there were no clinic visits to discuss relapse
treatment, physicians were blinded to allocation of each patient, and there was no ability
for investigators to assess time between acute relapse and initiation of treatment as a
component of autonomy. There are several strengths to this study including well
researched outcome measures, recruitment via media to generalize the population and
education provided by specially trained nurses or patients with MS to standardize
information and make the study transferrable to other populations.
The Center for Advancing Health (2014) has defined patient engagement as the
efforts to maximize the benefits of the healthcare services to which they have access.
Historically, individuals with MS had limited treatment options and DMTs had side
effects and risks. More recently, additional DMTs have been approved and now 13 such
treatment options exist. The addition of new DMTs has offered improved efficacy in
disease control but has also have increased side effects. Newer drugs have improved
ability to decrease the frequency and intensity of demyelinating and inflammatory
attacks, but increased drug efficacy means greater risk. This intensifies the need for
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patient education on treatment options and medication risks. (Center for Advancing
Health, 2014).
Bjornevik et. al. (2016) investigated the association between educational level and
risk of MS in a study comparing 953 patients with confirmed MS to 1717 healthy
controls. Norweigians were studied to eliminate geographical variations since this is a
known risk factor for MS. Subjects completed surveys about their educational level and
covariates of other known risk factors: smoking, exposure to mononucleosis, vitamin D
levels or sun exposure and body size. There were significant correlations between risk
factors and level of education. Patients with lower levels of education were more likely to
spend more time outdoors as an adolescent or be smokers. In this sample, there was a
statistically significant association between lower levels of education and risk of MS.
The limitations of this study included the presence of non-responders, which indicates
possible selection bias and surveys asking for recall of exposure to risk factors as
adolescents.
Bishop et. al. (2009) recognized that people who are diagnosed with a
neurological condition are likely to seek out information from various sources to educate
themselves about their condition and the future. The goal of this research was to identify
the most common tools patients utilize to gain information and therefore assist in making
recommendations on delivery of information and providing feedback to patients on how
best to access information. (Bishop, 2009). As part of a larger project, surveys were
mailed to 1000 people with MS with 409 returned for analysis. Respondents identified
the places they sought information from the most: internet, books or print, physicians,
support groups, local or national MS groups or other. Their findings showed that
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physicians (31.69%), the internet (27.94%) and local or national MS agencies (21.64%)
were the most popular sources of information. (Bishop, 2009). A limitation of this study
was physician sources of information did not specify physician specialty, suggesting that
respondents may utilize primary care physicians or non-specialists, leading to limited or
erroneous information. This implies the need for educational delivery in a group setting
to be delivered by the most qualified provider providers to ensure evidence-based
treatment options. Furthermore, reliance on the internet leads to concerns of quality and
accuracy of information. When provided the opportunity, healthcare professionals can
steer patients towards optimal internet resources to ensure accuracy. Lastly, the group
setting may be beneficial in establishing relationships early with supporting healthcare
providers such as therapists, mental health professionals and nurses who may have
expertise in the treatment of people with MS. An additional limitation of this work was
the likelihood of potential barriers to learning (vision, cognitive impairments) that may
limited educational options. (Bishop, 2009).
Somerset et. al. (2001) reported that patients who sought and gained access to
information about their MS were more likely to have higher quality of life, improved
psychosocial factors and decreased need for feedback or interaction with healthcare
professionals. Johnson (2003) proposed that information provided at or near the time of
diagnosis allowed patients to formulate opinions that may have a lasting effect on the
perception of disease progression. Furthermore, access to critical information on
prognosis, treatment, research opportunities, healthy lifestyle and patient rights was
associated with improved ability to communicate needs and participate in treatment
decision-making. (Bishop, 2009).
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Matti et. al. (2010) investigated the various types and volume of information
consumed by newly diagnosed patients with MS in Australia. This research followed up
on several studies that had shown people wanted more information than they received
from providers and expressed concerns about access to reliable source for information
and education. (Forbes et. al, 2007). Forbes et. al. (2007) specifically defined that
educational needs were the highest early in the disease process, suggesting this was a
critical time for patient education. Matti et. al. (2010) had 23 patients newly diagnosed
with MS attend an educational program about the disease and participate in data
collection. These 23 patients completed questionnaires over a nine-month period and
reported on the volume of information received from physicians, educational programs,
MS nurses, and the internet. In this study, the Multiple Sclerosis Society of South
Australia and MS specialist nurses provided the most appropriate amounts of information
after the diagnosis of MS and confirmed the correlation between of the amount of
information received and the professional providing the information. Responders
identified the MS Society of South Australia was the most preferred and relevant
provider of information. However, patients specifically wanted more information on
topics including the symptoms of MS, disease prognosis and disease management. This
study reported similar findings to the work of Somerset et. al. (2002) who found that
patients in their study also preferred education from nurses with specialized MS training
or certifications. Matti also reported that primary care physicians provided the least
relevant and smallest volume of information and confirmed the biggest need for patient
education was related to symptoms management. (Matti, et. al. 2010).
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Somerset et. al. (2001) surveyed 318 people with MS in Scotland and England
who responded to a questionnaire determining patient needs and expectations related to
healthcare services. The findings showed that 41% of patients wanted more feedback or
advice related to exercise, 33% desired additional information on diet and 25% requested
additional information on medications or alternative treatments. Additional data was
collected on frequency of healthcare visits within the past year. Few patients (39%)
reported having a consult with a physical therapist in the past year, suggesting a lack of
formal education or information provided on exercise. Only 16% of respondents reported
contact with an MS nurse specialist, but about 30% of patients reported that they wanted
that interaction. Additionally, respondents completed the Short-Form 36 (SF-36) which
showed poor self-reports health in almost every area except physical function.
Furthermore, respondent SF-36 scores indicated poor health status or quality of life when
compared to healthy individuals. One of the primary limitations of this study was that
some general practitioners requested their patients not participate in the survey-based
study. (Somerset, 2001). Somerset also described their study limitations to include the
general vagueness of surveys that do not allow for patient commentary. (Somerset,
2001).
Box et. al. (2003) surveyed 2030 people with MS to compare education received
with diagnosis year. In 1974 only 14% of patients diagnosed reported receiving formal
education. By 1990, this number had improved to 34% and in 2000 72% of patients were
provided with education about the disease. However, 28% of those diagnosed received
no formal education. Additionally, patients reported that the top five areas of education
they most desired at the time of diagnosis were: MS symptoms, symptom management,
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medications, disease course and contact with an MS certified nurse. The biggest gap in
education found by this study was the management of MS symptoms. (Box, 2003)
Box et. al. (2003) also surveyed patients to rate the level accessing information
about MS and approaches to treatment. Patients were asked to rate each survey item on a
five point scale ranging from “not difficult at all” to “very difficult.” Over 40% of
respondents reported that finding access to clinical trials, information about drugs,
emotional changes and new symptoms were difficult or very difficult to access. Patients
also responded that their preferred method of educational delivery for this information
would be via face-to-face contact with healthcare professionals, MS experts or through
leaflets. (Box, 2003).
Heesen et. al. (2007) defined the importance of shared decision making (SDM) in
the management of MS. The value of the SDM is the “two-way exchange of information
between physician and patient.” (Heesen, 2007; pg. 117). In this model, the physician is
able to apply evidence-based practice and the patient can offer personal experience and
perspectives on disease process and impairments. The study included 100 randomly
selected patients with primary-progressive MS from a database of over 1300 patients. Of
the 200 people contacted, 169 responded to questions about decisional role preferences,
MS risk knowledge and informational interests and preferences. Findings confirmed that
79% of participants preferred active decision-making roles. The survey also reported
information interest areas were treatment of symptoms (specifically gait impairments and
physical therapy), use of magnetic resonance imaging (MRI) information related to
relapses and complementary medication options. Furthermore, Hessen et. al. correlated
information interest to type of MS. MRI use was highest for patients with a relapsing-
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remitting course, while patients with primary-progressive MS were most interested in gait
changes and physical therapy. Limitations in the SDM model were some patients did not
want active decision-making roles and preferred the physician make critical decisions.
Trust between the patient and physician and the ability for both to work together to
maximize outcomes were other potential areas of concern. (Heesen et. al., 2007).
Baker (1998) interviewed 13 patients to collect data on MS exacerbation
experiences. The interviewees ranged from 32 to 56 years of age, included 10 women
and 3 men with MS histories between 1.75 years to 17 years. Baker studied the
knowledge gaps, questions, answer strategies and information barriers the patients had
during exacerbations. Data was collected in 1-2 hour recorded interviews for
exacerbation specific events over the course of the patient’s disease. The subjects
selected 39 events for further investigation and opportunities to ask professionals about
the nature of the symptoms experienced during an attack. Interviewers identified three
gaps in patient education: the physical symptoms experienced, emotions experienced and
lack of information about medications received during attacks. Not all patients sought
out information to answer questions during exacerbations, some reported reading material
was helpful, while some reported discussions with healthcare professionals were
beneficial. Patients reported confirmation of symptoms and the course of exacerbations
as helpful. Barriers to obtaining information were lack of up-to-date resources, generic
information that did not address specific situations and symptom denial limited the
pursuit of medical attention. Limitations in this study include the small sample size and
the interview strategy that allowed for analysis of multiple attack events.
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Bombardier et. al. (2005) defined health promotion as activities capable of
improving the general well-bring of patients, and potentially improving physical, social
and emotional health. Challenges of health promotion is the lack of provider time with
each patient, access to patient resources and funding issues. Also described was the
importance of patient responsibility to advocate for needs and participation in decisions
related to care. Bombardier et. al. described popular areas of self-advocacy as exercise,
stress management, social support, compliance with prescribed therapies and nutrition.
Chiovetti (2006) has referenced many studies that describe the high volume of
information that is required following a diagnosis of MS and the overwhelming nature of
this process. The author also described the importance of timing information delivery
with the management of MS, citing that “providing patients with appropriate and timely
information is a key component of MS care.” (Chiovetti, 2006 pg. 374). Health literacy
is an important aspect of patient education, which is the degree in which patients are able
to obtain, process, and understand health information or resources to make decisions
about healthcare needs. Effective health literacy requires that patient education be
modified to accommodate all levels of education and learning. Otherwise, patients with
lower education or literacy levels may not comprehend or misinterpret information,
which could lead to unmet healthcare needs and poorer disease management.
Chiovetti (2006) described barriers to learning in the healthcare setting, including
cognitive or visual impairments and varying educational level need. The author further
discusses the role of nurses with experience in MS as playing key roles in patient
education. Furthermore, the author recommended education should occur in friendly
environments where patients are not distracted or feel rushed.
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Chiovetti also

recommended that education be provided in multiple forms – written and verbal, and
should generally occur at appropriate levels for the general population.
Education is a critical component of chronic disease management and should be
provided to all patients. There are many possible delivery methods for education
including websites and blogs. For adequate education to occur, patients must have access
to educational programs and be able to understand and absorb the information being
provided. There are also many barriers to education, specific to people with MS
including access to resources such as the internet or specialists, access to quality
educational programs led by experts in MS care and cognitive or psychological
impairments affecting patient’s ability to advocate for themselves or manage their
disease.

Patients may also struggle to identify when to contact healthcare providers and

the responsibilities of each provider. There are many factors to be considered by the
patient and their family or caregivers at the time of diagnosis, including accepting the
implications of a chronic neurological disease. Patients may be overwhelmed with
information provided about a disease they have not yet accepted. Additional barriers to
education include lack of access to educational programs or the internet, which is a
popular method of information-gathering. One of the major values of patient education is
that it allows patients to be empowered to be their own advocate and participate in
decision-making related to their healthcare needs.
In recent years, the internet has become one of the most popular vehicles of
information for patients. Synnot et. al. (2014) reported that many patients utilize the
internet as a primary means to gain information about their diagnosis, but that many
patients report difficulty understanding information provided on websites. Synnot et. al.
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also reported that some of the most commonly utilized websites for patients to gain
information have low readability levels, which likely leaves patients with unanswered
questions or inadequate information. (Synnot, et. al. 2015).
Self-Efficacy & Advocacy
The National Mental Health Consumer’s Self-Help Clearinghouse “Technical
Assistance Guide to Self-Advocacy” defines attitudes and abilities required for selfadvocacy development. Two attitudes recommended for patients who wish to advocate
for themselves is to believe in themselves and be assertive. The Clearinghouse Guide also
discusses the importance of education, further citing the importance of early education
instead of reactive educational strategies. Although geared towards mental health,
patients with MS may also avoid information until a problem arises, which could delay
getting immediate information during an acute relapse. According to the Clearinghouse
recommendations, patients should educate themselves early and create their own
individualized set of accessible resources. Patients need to approach education from
every viewpoint and then tease out information that is specific to personal needs.
(National Mental Health Consumers’ Self-Help Clearinghouse).
Self-advocacy promotes the importance of patients breaking down a problem and
determining the most important part and taking action, according to the National Mental
Health Clearinghouse. Section 3 will further discuss how people with MS may have
impairments that prevent them from identifying the most important part of a problem or
recognizing what parts of the problem that can be impacted. (National Mental Health
Consumers’ Self-Help Clearinghouse).
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Bandura’s work has defined the necessity of self-efficacy in management of
disease and in overall psychosocial function. (Bandura, 1977) Furthermore, Bandura
defines self-efficacy as an individual’s beliefs about their ability to achieve the desired
outcome. (Hughes, 2015). This concept has been studied in multiple patient populations,
including spinal cord injury epilepsy and diabetes. (Hughes, 2015) Research with
various patient populations has indicated that self-efficacy is modifiable and highly
associated with functional outcomes and improved quality of life. (Aalto, 1997;
Tsaousides, 2009) Studies that have assessed interventions designed to improve selfefficacy have shown improvements in chronic disease management. (Aalto, 1997;
Northern, 2001).
Wilski and Tasiemski (2015) identified the relationships between treatment
beliefs, illness perception, self-esteem and self-efficacy and self-management of multiple
sclerosis. In surveys of 210 people with MS, specific factors related to self-management
were identified using multiple tools to identify personal factors that related to selfmanagement of the disease. In this study, the following tools were used: selfmanagement was assessed using the Multiple Sclerosis Self-management Scale –
Revised; illness perception was rated using the Brief Illness Perception Questionnaire;
self-efficacy was measured with the Generalized Self-Efficacy Scale; and self-esteem
was measures with the Rosenberg Self-Esteem Scale. The test-retest reliability,
predictive validity and concurrent validity of this tool were established by Broadbent et.
al. (2006). The research found women with MS had higher reported self-management
skills than men with MS and that individuals with higher education levels had higher selfmanagement scores. An important finding in this study was there is no significant
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correlation between Expanded Disability Status Scale (EDSS) and self-management.
Wilski and Tasiemski (2015) found that younger patients had higher scores on selfmanagement outcomes.
The EDSS is a 10-item ordinal scale reporting overall disability in MS. The scale
ranges from 0 (normal neurologic function) to 10 (death from MS) and is reported in
half-point increments. The EDSS is geared towards ambulation, reporting heavily on use
of assistive devices or wheelchairs. (Kurtzke, 1961; Kurtze, 1983). One critique of the
EDSS is that is lacks sensitivity towards mild changes in function or functional changes
not related to ambulation, and has limited interrater reliability. (Noseworthy et. al.,
1990).
Wilksi and Tasiemski (2015) also investigated the effect of personal factors on
self-management in MS. Findings suggested that patients with higher educational levels
scored higher in self-management, and women typically scored higher in selfmanagement than men. “The study participants who presented with higher general selfefficacy, long timeless perspective and perception that treatment can control progression
of the disease tended to have higher self-management levels.” (Wilski & Tasiemski,
2015, pg. 5). Wilski & Tasiemski (2015) found that improved self-efficacy resulted in
increased physical activity, improved compliance in disease control and progression and
higher self-management scores.
The importance of advocacy and self-advocacy has been described in the
literature related to various patient populations. The National Coalition for Cancer
Survivorship (NCCS) defines self-advocacy as the “continuum that begins when an
individual is diagnosed with cancer” and stresses the importance of patients being heavily
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involved in decision making in regards to their treatment. (NCCS, 2004). The National
MS Society defines self-advocacy as the “ability to effectively communicate an interest,
desire, need or right – and negotiate to get it.” (National MS Society) In addition, the
NCCS suggests patients “arm themselves with the tools and skills necessary to feel
comfortable about asserting yourself and communicating clearly about your cancer care
needs.” (NCCS, 2004). In their guide to becoming a self-advocate, the NCCS discusses
how disease and treatment self-education promote self-advocacy. Additionally, the
NCCS identifies changes in the modern healthcare system that requires patients to be
more active as advocates, including increased healthcare costs, limited referrals, staffing
shortages and strict reimbursement policies. The NCCS also described self-advocacy
benefits: decreased stress and anxiety, improved confidence, improved quality of life,
collaboration with peers and emotional support. There are four primary components of
self-advocacy: information-seeking, communication, problem-solving and negotiation.
(NCCS, 2004). In patients with MS, there is potential for cognitive or communication
barriers that may affect an individual’s ability to effectively advocate for themselves.
The National MS Society describes effective self-advocacy as awareness of
strengths and needs, ability to identify individual goals, and understanding of legal rights
and responsibilities. In addition, the National MS Society describes effective practices
for self-advocacy as situational needs assessment, consideration of ideal solutions,
identifying assistance and using an organized approach. In these practices, there may be
limitations for patients with MS because of psychological and cognitive impairments.
Cognitive impairments that may affect patients with MS include short term memory
problems, difficulty with information processing, impaired attention and impaired
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executive functions. Prevalent psychological factors affecting patients with MS include
depression, anxiety, grieving, coping issues and emotional problems.
Brashers et. al. (1992; 1999) described three critical components of self-advocacy
in patient with HIV: self-education, increased assertiveness, and mindful nonadherence.
Mindful nonadherence refers to the ability of a patient to make responsible decisions
when providers’ recommendations are not followed and to reject a proposed treatment or
treatment protocols outlined by the physician. Brashers et. al. found that patients that are
better informed about diagnosis are more likely to be compliant with treatments, which
can impact their long-term quality of life. They also found that assertive patients obtain
more information about their diagnosis and are therefore more involved in healthcare
decision-making.
Brashers et. al. (2009) designed and compared the Patient Self-Advocacy Scale
(PSAS) in patients with HIV (n=174) compared to healthy controls (n=218) and assessed
the reliability and validity of the measure. The PSAS is a patient-reported measure
composed of 12 items on a 1 (strongly agree) to 5 (strongly disagree) Likert scale. The
consistency of the PSAS was studied by comparing it to the Desire for Control Scale, the
Health Opinion Survey Instrument (HOSI), the Desire for Autonomy Scale and the
Health Locus of Control Scale. Reliabilities for the Desire for Control Scale were
established by Reed (1989) and Smith et. al. (1984). The HOSI measures preferences for
information seeking and behavioral involvement and reliability was established by Krantz
et. al. (1980). Reliability for the Desire for Autonomy Scale was determined to be .78 in
work completed by Ende et. al. (1989). The Health Locus of Control Scale measures
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internal or external locus of control and reliabilities were reported by Dahnke et. al.
(1994).
The findings of these studies concluded that the PSAS is reliable and valid for
measuring patient involvement in decision-making related to healthcare needs. Authors
concluded that the importance of measuring self-advocacy is related to “increased
healthcare participation and increased likelihood of nonadherence.” (Brashers, 2009).
Pickett et. al. (2012) studied educational offerings in the mental health sector to
determine the effectiveness of an 8-week peer-led program, The Building Recovery of
Individual Dreams and Goals (BRIDGES). This research cited the work of Brashers et.
al. (1995) that described patients who lacked knowledge about their diagnosis were less
likely to discuss their needs with healthcare providers and that many feel is it not
appropriate to ask questions or challenge their providers. The goal of BRIDGES was to
“empower mental health consumers by providing them with basic education about the
etiology and treatment of mental illness, self-help skills and recovery principles, and peer
support.” (Picket et. al. 2012, pg. 421). This eight-site study had 428 patients with
mental illness complete interviews prior to, at the conclusion and 6 months after the
BRIDGES program. The BRIDGES program was taught in multiple formats including
lecture, group participation and group discussion. The participants completed the 28item Empowerment Scale and an adapted version of the PSAS. (Brasher, et.al, 2009).
Excellent reliability and validity of the Empowerment Scale were established by Rogers
et. al. (2010). BRIDGES participants increased overall empowerment and
empowerment-self-esteem and self-advocacy, specifically assertiveness scores when
compared to the control group. Self-efficacy referred to the individual’s confidence in
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ability to control the environment, self-advocacy is the ability to represent and express
needs and wants. Self-esteem reflected a belief about one’s own worth. These three
attributes work together in effective self-management. At the 6-month follow-up
interview scores on empowerment and self-advocacy were maintained and showed the
lasting impact of this educational program. Limitations of the study are the lack of
observed participant involvement and peer and group leader interaction.
Cognitive Load Theory
The cognitive load theory has become one of the most significant areas of
educational research over the past two decades with a significant amount of literature
developed since first described. (Paas et. al. 2010). The cognitive load theory describes
situations in which learners are overwhelmed processing large amounts of information.
The basis of cognitive load theory is that long term memory appears to be unlimited,
whereas short term (or working memory) has limitations in both capacity and duration of
time in which information can be stored. Long term memory is easily accessed and
required to build on with new information. For learning to occur, working and long term
memory must work together.
Working memory has the primary function of processing new information before
it can be translated into the long-term memory. The estimated capacity for working
memory is 4 +/- 1 elements and the duration of storage of information is about 30
seconds. (Cowan, 2001). Information that is not stored or practiced within that 30second timeframe is not transferred to long-term memory. However, the limits of
working memory are resolved when dealing with familiar information as compared to
brand new information.
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The cognitive load theory was initially described to understand the limitations of
learners’ acquisition of new information. One critical component of the theory is that
instructors cannot overload or overwhelm the working memory, otherwise it fails to
accept new information and new learning cannot occur. (Paas, 2010). There are three
essential components of the cognitive load theory: intrinsic load, extraneous load and
germane load. Intrinsic loads are related to the complexity of the information to be
learned. Extraneous load are caused by poorly designed educational programming, and
germane load is the load of working memory that can handle intrinsic information. (Paas,
2010).
Another important component of the cognitive load theory is knowledge or
information can be borrowed or learned from other people instead of always relying on
personal experiences to create learning. The degree to which an individual attends to an
educational task is highly associated with the structure of educational delivery. (Paas,
2010). Therefore, the design of delivery for educational programming must always be
carefully considered.
Many researchers have identified potential strategies to manage the three aspects
of cognitive load theory in attempt to improve working memory and overall learning.
Instructional techniques focused on examining examples instead of active problem
solving allows learners to function more in working memory and relate this information
to known information within the long-term memory. Further recommendations include
limiting intrinsic loads, which can potentially result in rapid overload of the working
memory. Management of intrinsic load can be accomplished by initiating education with
simple tasks and building from those. (Paas, 2010).
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Coping, Cognitive and Psychological Impairments in MS
In a study of 140 patients with MS using standardized mental health measures as
defined by the DSM-IV, several common psychological diagnoses were identified.
(Korostil, 2007). Anxiety was identified in 35.7% and generalized anxiety disorder was
found in 18.6% of patients, with greater risk found in females and individuals with a
history of depression. (Korostill, 2007). The work of Korostil and Feistein (2007)
indicates that although psychological impairment is common in MS, these diagnoses are
often overlooked by neurologists and go untreated, suggesting that many patients may be
dealing with psychological dysfunction in addition to the recent diagnosis of a
progressive neurological condition.
The work of Chwastiak et. al. (2002) investigated a large sample of people with
MS and found 41.8% of patients had evidence of depression. Furthermore, the risk of
depression across the lifespan was estimated to be 50%. (Chwastiak et. al., 2002). When
comparing these findings to other chronic medical conditions including asthma, diabetes
and epilepsy, the incidence of depressive diagnoses are more common in MS. (Kern,
2009).
Wineman et. al. (1994) studied 433 patients with MS and 257 patients with spinal
cord injury (SCI) to evaluate coping behaviors specifically related to an individual’s
uncertainty about an illness and ability to cope with some degree of uncertainty. In this
study, two factors of coping were identified: the emotion-focused coping (EFC)
behaviors and the problem-focused coping (PFC) behaviors. (Wineman, 1994). Previous
research by Folkman and Lazarus (1980) determined that EFC behaviors are more often
used health-related stress, and PFC behaviors are more likely to be associated with work
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stress. (Folkman & Lazarus, 1980). Patient vulnerability was a critical variable
identified in the literature. Without vulnerability, there were significant differences
found in the types of coping (EFC vs. PFC) used by patients. (Wineman et. al. 1994)
Their research found that patients employ different types of coping when different types
of situations occur, thus defining the need to teach multiple coping strategies to patients.
Wineman et. al. states that “Clinicians need to be aware that under conditions of high
illness uncertainty and appraisals of danger, the individual is at risk for negative
emotional outcomes. (Wineman et. al., 1994, pg. 193). Illness uncertainty might be
higher, if not at a peak, in patients that have recently been diagnosed with a disorder such
as MS.
Sadovnick et. al. reported the incidence of depression in patients with MS to be
about 50%. Depression can be linked to cognitive impairments such as problems with
attention, reasoning, executive functions, memory or judgment. Another study estimated
the incidence of these cognitive impairments to be as high as 60-65%. (Polman, et. al.
2006). However, there is not clear research to establish the specific cause of depression
in patients. (Lynch, 2001). Lynch (2001) used a sample population of 188 patients with
MS to measure psychological function using the following tests: Self-Rating Depression
Scale (SDS), The Ways of Coping (WOC), the Hope Scale (HS) and the Uncertainty of
Illness Scale (UIS). These results differed from a study by Mohr (1997) by noting
insufficient findings linking coping as a intervening variable between disability and
depression. Mohr (1997) found that patients with high impairment levels also had higher
scores for depression, escape-avoidance coping and problem solving, while Lynch (2001)
found correlations between impairment groups to be more similar. Lynch et. al. also
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reported that depression in patients with MS was not necessarily related to an individual’s
disability status, hypothesizing that patients of all levels of functionality are likely to
experience depression. (Lynch, 2001). The biggest limitation of the research performed
by Lynch et. al. is that it failed to define coping as a variable of depression and disability,
which differs from the research by Mohr et. al. (Lynch, 2001).
Many studies have described the relationship between level of disability and
incidence of depression. Mohr et. al. (1997) surveyed 91 patients with MS on various
mental health measures, including depression using the Beck Depression Inventory,
coping using the Ways of Coping Inventory (WOCI), and level of neurological
impairments using the Expanded Disability Status Scale (EDSS). Participants were
divided into groups based on level of impairment according to EDSS scale as determined
by a neurologist. In this correlational analysis there were two possible outcomes to
consider. The first model considered coping as a response to depression. In this model,
treatment for depression may be indicated, as increased levels of neurologic impairment
appears to produce depression. Therefore, treating the depression may allow for
improved ability to utilize coping behaviors. An alternative hypothesis suggested that
depression is a response to coping. In this example, “increasing neurologic impairment
reduces one’s adaptive coping abilities which results in a greater level of depression.”
(Mohr, 1997). For these individuals, treatment should likely focus on improving adaptive
coping skills to decrease or manage depression. However, the authors suggest that these
examples are not mutually exclusive, and that coping skills may affect psychological
function and vice versa. Mohr also reported that patients with higher EDSS scores
(defined as greater than 6.5) had increased prevalence of depression and utilized more
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avoidance behaviors in coping with their disease. Patients with EDSS scores less than
7.0 were associated with a lower prevalence of depression, but used more problemcentered strategies to cope with their diagnosis and disease progression. There were two
significant limitations of this research: the lack of information on patient cognitive status
and a low (46%) response rate. Without prior knowledge of cognitive status, it would be
difficult to determine whether those impairments are associated with depression and
coping. The authors also recommend use of a depression-screening tool such as the Beck
Depression Inventory, and noted that although providers tend to be aware of
psychological problems in this patient population, early recognition was important in
treatment. The significant of this research was that it suggested a correlation between
significance of neurologic impairment and risk of depression. It also reported that
patients with depression who are more advanced in their disease process are more likely
to utilize maladaptive coping behaviors. (Mohr, 1997).
There is limited research that has specifically looked at psychological factors
early on in the disease processes. Kern et. al. (2009) considered this time frame as being
critical in terms of psychological issues affecting quality of life. In this study,
psychological stress affecting health-related quality of life within the first three years
since diagnosis of MS was studied. (Kern, et. al., 2009). Patients with MS were
interviewed at 6-month follow-up appointments and EDSS scores were updated. Surveys
completed during the interview included the Symptoms Checklist-90-Revised (German
version) which is a self-reported measure to assess psychological distress in the following
areas: obsessive-compulsiveness, interpersonal sensitivity, phobic anxiety, somatization,
depression, anxiety, hostility, paranoid ideation and psychoticism. Participants also
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completed the Functional Assessment of Multiple Sclerosis Quality of Life (FAMS)
scale, a 59-item self-reported quality of life measure. Kern et. al. (2009) reported on 31
patients within 36 months since diagnosis and compared to 24 healthy individuals on
patient-reported outcomes of psychological distress and quality of life. Findings
concluded that psychological distress was more prevalent in patients with MS as
compared to healthy controls. There was also a negative correlation between EDSS
scores and quality of life, specifically for mobility, contentment and emotional wellbeing. In patient-reported outcomes, individuals with a higher EDSS score reported lower
quality of life. Furthermore, patients with relapsing-remitting MS reported increased
somatization, obsessive-compulsiveness, interpersonal sensitivity, anxiety, paranoid
ideations and psychoticism. Limitations of this work included the cross-sectional design
for assessing the relationship between psychological stress, neurological disability and
quality of life, which limited the ability to determine exact causality. In this study, the
sample size was on 31 patients, which makes the results less generalizable. Additionally,
the sample size was small and potentially biased, making the results less generalizable.
This work confirmed the presence of significant psychological distress in early-stage MS
as compared to healthy controls. It also defined psychological stress in early MS is not
necessarily correlated with level of functional or neurological disability. (Kern, 2009).
Smith et. al. (2000) also evaluated patients in early stages of MS and reported increased
level of distress compared to healthy controls, suggesting that psychological distress is
not necessarily related to the neurological disability but instead may be associated with
the social and emotional demands associated with receiving a diagnosis of MS. (Smith,
et. al., 2000).
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Some research exists that investigates illness perception in MS. Smith et. al.
(2000) defined the effect of psychological distress on illness perception in MS. This
work compared the perception of disability of a patient with MS and depression to the
perception of disability their physician reported and compared to individuals that were
not depresses. These researchers hypothesized that patients may have a negative
perception of treatment effectiveness. (Smith, 2000).
The correlation between psychological impairment and employment status was
been studied by Moore et. al. (2013). Their findings concluded that individuals with MS
who left the workforce, decreased their workload by job modification or moved to parttime positions reported increased levels of disability when compared to individuals who
continued with fulltime employment. Additionally, when job changes were made, those
individuals also reported increased levels of fatigue, increased cognitive impairments and
more mobility issues. (Moore, 2013). Other patient-reported issues were described
related to cognitive impairments such as delayed processing and memory impairments.
(Rumrill, 2015).
Emotional Intelligence (EI) has been defined as the “ability to manage feelings or
emotions” and includes components such as perception, understanding and regulation of
emotions. (Ghajarzadeh, 2014). In one study 166 patients with confirmed diagnoses of
MS were compared to 100 healthy controls to evaluate the EI as a factor in MS. Results
showed that EI scores were significantly lower in those with MS when compared to
healthy controls, inferring that the disease may affect the ability of individuals to regulate
emotions. This study also determined that EI was not significantly different in men and
women regardless of the presence of MS. (Ghajarzadeh, 2014).
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Guiding Contemporary Research
The Cochrane Collaboration (2014) performed a comprehensive literature review
on information provided to people with MS. Over 1300 patients in 10 different studies
from the United States, Germany, the United Kingdom, Italy, Belgium and Australia
were included in the analysis assessing various approaches to educational delivery. The
age range for patients in these studies was 31-51 years old, and 60% of the participants
were women. The conclusion of this analysis only presents low-moderate quality
research indicating the need for additional studies in the area of education for people with
MS.
The Cochrane Collaboration (2014) reviewed four studies (524 patients) that
looked at understanding of MS, there were significant differences in patient knowledge
following intervention. However, there is only moderate level research to support these
studies based on the presence of bias.
An additional four studies assessing decision-making in patients with MS were
analyzed with low quality research to support claims based on bias and inconsistency.
The research by Kopke et. al. (2009) suggested there is a significant difference in a
patient’s ability to play an active role in decision making when provided with patient
education. Two studies that showed no difference in decision-making or role preference
in patients that were educated about their disease. (The Cochrane Collaboration, 2014).
Five studies analyzed in The Cochrane Collaboration (2014) assessed the effects
of education in MS on quality of life. Two studies reported improvements in some of the
sub-scales of the Short-Form 36 (SF36), a general scale used to assess quality of life in
many patient populations. Both of these studies (Ennis, 2006; O’Hara, 2002) showed
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improvements in the mental health scale of the SF36 after providing patient education.
However, both of these studies were low quality based on the presence of bias and
inconsistencies as identified by the Cochrane Collaboration review.
The last outcome group assessed in the Cochrane Collaboration (2014) reviewed
the frequency of adverse effects related to educational programming in patients with MS.
Six studies were analyzed, including 765 patients, and no adverse events were reported.
Mulley et. al. described recent advances in medical interventions and the
importance of physicians understanding all potential treatment options as well as
associated risks, benefits or side effects. These authors also point out the flawed
assumption that doctors are the experts and ultimately know best in terms of diagnosis
and treatment. Mulley et. al. also discuss two types of diagnosis: the medical diagnosis,
and the patient preference diagnosis, which is often silent. A preference misdiagnosis
occurs when patients are given treatments that are not their first option, or when other
options may not have been offered. These misdiagnoses also occur when patients
perceive one treatment as being superior based on the notion that “physicians know best.”
A cross-sectional descriptive dissertation has been completed investigating the
relationship between patient-related learned helplessness and disease status, functional
disability, social disability and disease activity in MS. Learned helplessness is “a
generalized expectancy of non-contingency between response and outcome” that patients
with chronic illness are at high risk of developing. (McGuinness, 1995). Learned
helplessness has been associated with poorer health outcomes and is indirectly associated
with impairments of cognitive function, affective health and motivation. This
dissertation study included 72 patients with MS in Canada who had been diagnosed for at
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least one year and recorded the Minimum Record of Disability, Kurtzke’s Functional
Systems and the Disability Status Scale, the Incapacity Status Scale, the Environmental
Status Scale, the Learned Helplessness Scale and demographic data. Patients voluntarily
completed these scales at the time of clinic appointments, or were visited to complete the
measures. The study included 72 patients (50 female, 22 male), fifty percent of
participants with at least some university education, and 34.7% that were currently
employed. (McGuinness, 1995).
The research concluded that there is a statistically significant correlation between
learned helplessness and increased social disability, employment status and between
disease status functional disability and social disability. The study found a weak positive
but statistically non-significant relationship between disease status as rated on the
Disability Status Scale and learned helplessness. This study concluded that patients with
MS are susceptible to learned helplessness given the chronic nature of the disease.
However, learned helplessness is likely to decrease with disease duration, suggesting
patients learn to cope or manage the effects of their disease over time. Patients that are
involved in disease management and effectively advocate for their needs may be less
likely to experience learned helplessness, further providing support to the importance of
promoting patient education and advocacy.
MS is a variable but progressive neurological condition that affects each
individual differently, establishing the need for individualized education. The variability
of the disease is indicative of the uncertainty patients experience in coping with the
diagnosis of MS. Decision-making is a critical part of autonomy and management of MS
and ranges from DMT to management of acute relapses and adjunctive therapies. The
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increasing number of available treatment options requires additional education and
support from healthcare providers. There are multiple barriers to patient education in MS
including cognitive impairments, access to education, ability to understand material,
accuracy and timeliness of the delivery of education, and the cognitive load theory.
There are several studies showing the importance of educational programs for patients
and investigating the efficacy of various delivery styles. Providing accurate, timely and
evidence-based education to patients with MS is a critical part of autonomy and selfmanagement.
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CHAPTER 3 – METHODOLOGY
Introduction
In the past two decades, research has shown the effectiveness of treatment options
for patients such as disease-modifying therapies and the benefits of a multi-disciplinary
approach to treatment in managing multiple sclerosis (Burks, 2000. Halper, 2010.
Namey, 2010). However, many patients either live in areas where access to care is
limited or they are not provided with the appropriate information to advocate effectively
in managing their disease. There is no standard as to the optimal timing and amount of
information to provide to patients after receiving a diagnosis of MS.
Treatment of MS includes medication management and monitoring of disease
progression by a physician or nurse practitioner. There is also a significant amount of
research to indicate the benefits of a multi-disciplinary approach of services and
education from nursing, rehab experts, social workers, nutritionists, and mental health
practitioners and others. Due to the wide range of clinicians involved in care, there is
potential for education to be completed in various settings although there may be little to
no communication between providers.
One of the challenges of caring for patients with MS in rural areas is the lack of
access to specialty services. Larger healthcare systems often have expert clinicians and
support staff available to participate in patient education. Here, a common educational
model is offered to newly diagnosed patients to improve patient understanding of their
diagnosis and be provided with strategies for disease management.
At Norton Healthcare, an educational program- titled MS 101 is offered quarterly
in attempt to address the educational needs of patients with a new diagnosis of MS. The
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diagnosing neurologist encourages patients to attend the next available course following a
definitive diagnosis of MS. However, depending on the timing and patient availability,
several months or even years may pass before an individual attends this program. In
other cases, patients may be attending the program within the first few weeks of
diagnosis. In MS 101, an MS-specialist nurse navigator and a licensed marriage and
family therapist provide the educational programming.
Topics in MS 101 include information about the pathology, medications (diseasemodifying and adjunctive therapies), relapses vs. pseudo-relapses, signs and symptoms,
the disability process, employment issues and an introduction of the medical and support
teams. The course is approximately four hours long with intermittent breaks.
Some barriers that arise in education is patient cognitive load, (the ability to
absorb large amounts of information), and possible cognitive impairments in patients
with MS. Ultimately, patient education in chronic, progressive conditions is critical and
provides patients with the ability to empower themselves, improve their quality of life
and ensure optimal medical management.
Statement of the Problem
There are a wide variety of educational models offered to patients with MS. This
has led to patients either being given too much, too little or poorly timed information in
relation to their needs. Sweller et. al. (1998, 2993, 2004, 2005) has shown that the
cognitive load theory plays an important part in understanding what people can absorb
and retain at any given time. In patients with a neurologic disease, there is also potential
that cognition may play a role in optimal timing, amount and pedagogy of patient
education. This may lead to patients not understanding the information they are being
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presented, or not being able to process the large volume of information that is bring
provided.
Self-advocacy is an important part of patient education. Optimally, patients
should be able to advocate for their healthcare needs and have better control of the
disease process, which improves the quality of life. This research study aims to provide
guidelines to optimize educational programs developed for patient understanding, selfadvocacy, quality of life and functional outcomes.
Research Questions
Research Question 1: How does the timing of patient education affect self-advocacy in
patients with MS?
Research Question 2: How does the amount of information provided to patients with MS
impact their self-advocacy?
Research Question 3: What demographic information correlates with self-advocacy?
Research Question 4:What are the optimal time frames in which diagnosis education
should occur?
Research Question 5: How much information can patients with a progressive neurologic
condition absorb in the acute phase of diagnosis?
Hypotheses
H1 (Null): There is no relationship between the timing of education and patient selfadvocacy.
H1 (Alternate): There is a relationship between the timing of education and patient selfadvocacy.
H2 (Null): The amount of education has no impact on self-advocacy.
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H2 (Alternate): The amount of education provided negatively impacts self-advocacy.
H3 (Null): There is no correlation between demographics and patient reported selfadvocacy.
H 3 (Alternate): There is a correlation between demographics and patient reported selfadvocacy.
H4 (Null): There is no correlation between timing of patient education and selfadvocacy.
H4 (Alternate): There is a correlation between the timing of patient education delivery
and self-advocacy.
H5 (Null): There is no relationship between the amount of information provided to
patients and reported self-advocacy.
H5 (Alternate): There is a relationship between the amount of information provided to
patients and reported self-advocacy.
Population and Sample
This study will use volunteers from the Norton Healthcare system neurology
department as subjects. All patients diagnosed with MS at Norton Healthcare have
opportunities to attend the MS 101 courses. Patients involved with the Norton
Neurologic Resource center or receiving therapies at the Norton Neurosciences & Spine
Rehabilitation Center are also encouraged to attend by therapists. MS 101 is offered in
May, August and November in 2016 so patients will have the opportunity to attend a
convenient course. All participants will be over the age of 18 at the time of diagnosis.
The ability to recruit patients will be impacted by the number of diagnoses made in the
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recruitment window, but the sample size goal is 30 individuals. Typically, each MS 101
course has about 5 attendees.
Eligibility criteria for this study were: (a) confirmed diagnosis of MS, (b) ability
to sign informed consent, (c) attendance at MS 101 course at Norton Healthcare during
the data collection period. Only patients who do not wish to participate will be excluded.
Patients requiring assistance will be permitted to use family, caregivers, support staff or a
researcher to complete surveys.
IRB approval was obtained through the University of St. Augustine on March 31,
2016 with permission from Norton Healthcare. Patient confidentiality was maintained
throughout the study in accordance with all Health Insurance Portability and
Accountability Act (HIPAA) to protect patient privacy. Informed consent was reviewed
with each participant and signed prior to the start of the MS 101 program.
The MS 101 course is a four-hour program offered quarterly at Norton Healthcare
for patients and families/caregivers diagnosed with MS within the past two years. A
nurse navigator and a licensed family and marriage therapist teach the course, each
covering their areas of expertise. Material to be covered in the course includes MS
pathology and pathophysiology, symptoms, disease-modifying therapies, adjunct
treatments, the multi-disciplinary team, relapses and pseudo relapses, coping and
depression, and work and family issues. An MS research coordinator visits briefly to
introduce the research team and describe current studies, and provides contact
information should patients wish to get involved in clinical trials. A representative from
the MS Society provides literature and contact information to patients. The course is
given to small groups with PowerPoint presentations and handouts.
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Instrumentation
The Patient Self-Advocacy Scale (PSAS) was selected as a self-advocacy
outcome measure based on its extensive use in the literature for patients with cancer and
Human-Immunodeficiency Virus (HIV) or Acquired Immune Deficiency Syndrome
(AIDS). The PSAS assesses assertiveness in healthcare decision-making, illness,
treatment education and healthcare interactions. (Brashers, 1999). It is a patientcompleted 12-item questionnaire reported on a 5-item Likert scale ranging from strongly
agree to strongly agree.
Validity and reliability of the PSAS was reported by Brashers et. al. (1999) using
a sample of 218 patients with HIV-AIDS. Sample group 1 included 174 patients; sample
group included 218 healthy controls recruited by convenience. The combined sample
was given an 89-item questionnaire that included random placement of the 12 PSAS
items. The PSAS scores were tested for validity by comparison with the Desire for
Control Scale (Burger, 1992), the Health Opinion Survey Instrument (HOSI: Krantz et.
al., 1980), the Desire for Autonomy Scale (Ende et. al., 1989) and the Health Locus of
Control Scale (Dahnke et. al.,1994).
Reliability for sample group 1 was 0.60 for education, 0.67 for assertiveness, 0.82
for nonadherence and 0.78 overall, calculated using Cronbach’s alpha. Reliability for
sample group 2 was 0.61 for education, 0.69 for assertiveness, 0.7 for nonadherence and
0.78 overall. Reliability of the combined sample was reported as 0.64 for education, 0.70
for assertiveness, 0.79 for nonadherence and 0.78 overall.
Validity was assessed by use of construct and criterion measures, including
patient reported participation in activist groups compared to those not involved in activist
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groups. Construct validity was confirmed with comparison of other measures including
the Desire for Control Scale and HOSI.
Additional demographic information was collected, including age, gender, race,
marital status, household income, education level, history of previous MS education, date
of diagnosis and occupation. This information was collected for correlational analysis.
Data Collection Procedures
As patients arrived to the MS 101 program, the primary researcher introduced
herself, explained the project and inquired if patients were willing to participate. It was
explained that participation was completely voluntary. If agreeable, the consent form
was reviewed and signed by the participant, the researcher and a witness (staff from the
Norton Resource Center). Due to the small number of participants in the programs,
consent forms were reviewed individually with each participant. Pre-course PSAS
surveys, demographic forms and consent forms were collected prior to the start of the
program. Post-course surveys were handed out at the conclusion of the program and
immediately collected by the researcher when completed. The researcher transported all
research materials to a secure office at Norton Healthcare for storage.
Procedure
Patients will be recruited for the MS 101 course as part of the standard of care at
Norton Healthcare. Patients are encouraged to attend at diagnosed and subsequent
medical appointments with the neurologist. Additional recruitment may occur from
support staff in the physician practice or the Norton Neurologic Institute Rescore Center
(NNIRC), where the MS Nurse Navigator, mental health, social and lay navigators are
located. Patients sign up for MS 101 course in advance by registering with the NNIRC

46

staff who run the program. Upon arrival to the program, each individual will be asked if
they wish to participate, and the consent will be reviewed and signed at that time. The
patient will complete the demographic form and the PSAS prior to the start of the
program. They will be asked to repeat the PSAS at the conclusion of the four-hour
program. Patient information will be encoded to protect patient confidentiality and for
data analysis purposes. Coding in Microsoft Excel will include: gender (male – 1, female
= 2), marital status (single = 1, married = 2, divorced = 3, widowed = 4), previous MS
education (no = 1, yes = 2), ethnicity (Caucasian =1, African American = 2, Hispanice =
3, Other = 4), known family members with MS (no = 1, yes = 2), formal education level
(middle school = 1, high school graduate = 2, vocational school graduate = 3, some
college = 4, bachelors = 5, masters = 6, doctorate = 7) , current employment status (full
time = 1, part time = 2, unemployed = 3, retired = 4) and household income (<$25k = 1,
$25-50k = 2, $50-100k = 3, > 4100k = 4). PSAS items were coded for data analysis as
follows: strongly agree = 1, somewhat agree = 2, agree = 3, somewhat disagree = 4,
strongly disagree = 5. All research materials will remain in the possession of a researcher
and will be locked in a storage drawer that only the researcher has keyed access to. The
drawer will be contained in a locked office at Norton Healthcare.
Data Analysis
Data analysis will be completed using the Statistics Package for Social Sciences (SPSS).
Means will be calculated for age, time since diagnosis and additional demographic data.
This study is a correlational quantitative research design.
Dependent Variables
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The dependent variable is what the study presumes to be affected by the
independent variable. In this study, the dependent variables will be 1) the patient’s
perception of their abilities as a self-advocate; 2) the amount of information retained from
post-diagnosis educational programs.
Independent Variables
The independent variable is the component that is being manipulated by the study.
In this instance, the independent variable is the timing and amount of education being
provided to these patients. Patients will be coded for data processing including male = 1,
female = 2. Other demographic information will be recorded including marriage status,
previous formal education about MS, education level, family history of MS, ethnicity,
employment, household income and occupation.
Descriptive statistics will be completed for mean, standard deviation, range for all
demographic information. When appropriate, this data will be reported in percentages.
The P value <0.5 will be used to support alternate hypotheses. Pearson correlation
coefficient will be utilized to examine relationships between pre-PSAS scores and ages,
and pre-PSAS scores and amount of formal education. Dependent samples t-testing will
be utilized to examine the relationship between pre and post overall scores, while also
reporting a standard deviation and standard error. Spearman’s rho calculations will be
processed to assess for any correlation between education level and changes in pre versus
post testing scores can be identified. An additional Spearman’s rho will be calculated to
assess and statistically significant changes between pre and post PSAS scores when
compared with the time period since diagnosis.
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Confounding Variables
The potential for a multi-center may result in various instructors, which could be a
confounding variable. The potential for variation in the number of patients being
diagnosed and their ability to attend educational programs based on dates, times and
location would be additional confounding variables. There is potential for variation in
instructors of the programs, and potential for varying sizes of the programs, both of
which may be viewed as confounding variables that may affect patient-reported data.
Additional confounding variables would include psychosocial factors and
individual comorbidities. Issues such as anxiety and depression are common in
individuals with MS and these factors might impact motivation and engagement in
educational programming. Support from family members could play a role in individuals
attending or their motivation for attendance at MS 101 courses. There is potential that
individuals were unable to attend programming without encouragement from caregivers
or support for transportation or other psychosocial needs.
Ethical Issues
During review of the consent forms, the researcher explained that there are no
direct benefits of participation to each patient but that the overall goal was to make
recommendations for future educational programs. It was also explained that the
researcher is completing this project as a dissertation project for a doctorate in education
at the University of St. Augustine. The researcher disclosed that she was employed by
Norton Healthcare as a physical therapist in the neurologic institute. There was the
potential for participants to feel pressured to participate based on the presence of experts
in the field and the introduction of the researcher as a member of the MS team. It was
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reiterated that participation in voluntary and disclosed that physicians would not be aware
of participation to dissolve any concerns about participation affecting care. The
researcher also reviewed the coding procedure to protect patient identify if enrolled in the
study.
Limitations and Delimitations
One potential limitation of this study is the potential sample size. Subjects will be
recruited through the neurology department, but will rely on the number of diagnoses
made during the time frame for data collection. Other limitations include the location
and times of the educational programs, which may not be accessible or convenient to all
potential subjects. If follow-up data is to be collected, there is potential that individual
could relocate, leave the practice or choose not to participate in this portion of the study
and would therefore limit long-term data collection.
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CHAPTER 4 - RESULTS
Introduction
The study outlined here was quantitative and utilizes primarily descriptive
statistics with inferential statistics to make predictions about the population studied. All
descriptive and inferential statistics were analyzed using the Statistical Package for Social
Sciences (SPSS, 2016). The alpha level for rejecting the null hypothesis was established
at the .05 probability level and all statistics reported are two-tailed unless otherwise
specified. Over three MS 101 courses, a total of 11 participants were enrolled in this
study.
Study Participants’ Demographics
Demographic data for the eleven participants was collected to analyze
relationships between demographics characteristics and pre- or post PSAS survey scores.
Demographic data is reported in tables and described below.
Table 4.1 shows the ages of participants in the MS 101 courses from May 2016 –
November 2016. The average age was 42.55 years, with the youngest participant being
30 years old and the oldest at age 67.

Table 4-1. Descriptive Statistics for Age of Study Participants
Variable

Age

n

M

11

42.55

51

SD
10.17

Table 4-2 shows results from demographic data regarding marital status. Eight of
the participants were married, two reported being single and one reported being divorced.
Table 4-2. Descriptive Statistics Marital Status of Study Participants
Frequency
Percent
Single
2
18.2
Married

8

72.7

Divorced

1

9.1

Total

11

100.0

Table 4-3 shows the number of children each participant has. Four patients do not
have any children, three participants have one child, two participants have two children
and one participant has 5 children.

Table 4-3. Descriptive Statistics for Number of Children of Study Participants
Frequency
Percent
No Children
4
36.4
One Child

3

27.3

Two Children

2

18.2

Three Children

1

9.1

Five Children

1

9.1

Total

11

100.0

Table 4-4 shows that 10 of the 11 participants were Caucasian, and the other
being African American.
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Table 4-4. Descriptive Statistics for Race of Study Participants
Frequency
Percent
Caucasian
10
90.9
Black

1

9.1

Total

11

100.0

Table 4-5 reports the number of participants who have known family members
with MS, which was one of the 11 participants or 9.1% of the sample size. This
information is of particular interest given the known genetic component of MS as
previously discussed.

Table 4-5. Descriptive Statistics for Family Members with MS
Frequency
Percent
No
10
90.9
Yes

1

9.1

Total

11

100.0
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The highest level of completed formal education was collected from each
participant and results are shown in Table 4-6. The goal of collecting this data was to
correlate changes in self-advocacy and pre- and post survey results based on education
levels. All participants in the study had completed high school, with two completing
some college education, three completing a bachelor’s degree, three completing a
master’s degree and two with doctoral degrees.
Table 4-6. Descriptive Statistics for Level of Education of Study
Participants
Frequency
Percent
HS Grad.
1
9.1
Some College

2

18.2

Bachelors

3

27.3

Masters

3

27.3

Doctorate

2

18.2

Total

11

100.0
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Employment status was collected to evaluate whether or not participants were
working at the time of the MS 101 courses and if so, employed on a full time or part time
basis. This is reflected in Table 4-7. Employment status is relevant for patients with MS
as the disease is known to affect an individual’s ability to maintain full time employment
long term. Of the eleven participants in this study, 10 were working full time at the time
of participation in the MS 101 course. One participant reported they were retired at that
time.

Table 4-7. Descriptive Statistics for Employment Status of Study Participants
Frequency
Percent
Full Time
10
90.9
Retired

1

9.1

Total

11

100.0

The average household income was assessed and is reported in Table 4-8. One
participant (9.1%) reported the household income of less than $25,000 per year, most
(63.6%) reported household income between $50,000-$100,000 annually, and three
participants (27.3%) reported household income of over $100,000 per year.
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Table 4-8. Descriptive Statistics for Household Income of Study Participants
Frequency
Percent
< 25k
1
9.1
50 – 100k

7

63.6

> 100k

3

27.3

Total

11

100.0

Central Hypothesis Number One
Descriptive statistics for pre- and post PSAS scores for each survey item are
described Table 4-9. Of interest are changes between the pre- and post survey scores on
each item. Increased numeric values indicate improved subject perceived ability for selfadvocacy. Scoring of the PSAS was coded as 1 = strongly agree to 5 = strongly
disagree). The mean score for PSAS item 1 was 1.09 both pre and post showing that
there was no change in scoring for that survey item. Survey item 1 asked about the
participant’s perceived belief that it is important to be educated on their health and
diagnosis. Item 2 showed an increase in mean from 1.64 pre MS 101 course to a mean
score of 1.73 post MS 101. This survey item asked how likely a participant is to actively
seek our information about their health. Increased scores here may indicate that patients
may be slightly less likely to seek out information about their diagnosis following the MS
101 course.
Item 3 on the PSAS had a mean scored of 2.18 pre course and a post course mean
of 2.00 showing a decrease of 0.18. This survey item asked if the patient feels they are
more educated than the typical United States citizen about health. The decreased score
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suggests there are slightly increased feelings of being more educated than the typical U.S.
citizen about their health following this educational program. Item 4 had a pre course
mean of 3.73 that decreased to 2.55 post course. This survey item asked participants
about their knowledge of health-related problems; the decreased score of 1.18 suggested
an improved sense of understanding their condition.
Item 5 had a pre-course mean of 3.55 that decreased to 3.0 in post-course surveys.
Survey question number 5 inquires about a participant’s assertiveness with their
physician and perception of needs being met by their physician. Decreased scores
suggests that patients at the end of the MS 101 course felt slightly more likely to act with
assertiveness during discussions with medical providers.
Item 6 had a pre course mean of 2.91 that decreased to 2.64 post course. This
survey item asked if the participant perceived that they are more or less assertive than
most US citizens in terms of their healthcare needs. The decreased score here suggested
that participants felt more assertive following the educational program.
Item 7 had a pre course mean of 3.00 and post course mean of 3.00, indicating no
change in average scores on the survey item about the patient’s ability to make
suggestions to their physician about their healthcare needs.
Item 8 had a pre course mean of 1.55 and a post course mean of 2.64 suggesting
that participants were less likely to question physicians about recommendation they did
not agree with following the educational program.
Item 9 assessed whether or not participants felt that there were good reasons not
to follow the physician advice. The mean score was unchanged between pre- and post
surveys.
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Item 10 asked if participants felt they had a better grasp on what their needs were
than their physician. In pre course surveys, the mean score for this item was 3.64, which
decreased to 3.45 in post course analysis. The change in scores here suggests that
patients generally felt that their awareness of their needs increased following the MS 101
program.
Item 11 asked if the participant was likely to follow physician advice even if they
did not agree with the advice. In pre course surveys, the mean score was 2.91 which
increased to 3.64 in post course surveys. This change in score suggested that patients
were more likely to advocate for their beliefs following the education program when in
disagreement with their physician.
Item 12 asked how often participants were noncompliant with physician
recommendations. On pre course surveys, the mean score was 3.73 which decreased to
3.27 in post course analysis. This change in score suggests individuals were less likely to
not comply with physician recommendations after the education program compared to
previous understanding.
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Table 4-9. Descriptive Statistics for Pre and Post PSAS Scores

Pre PSAS

Post PSAS

Item

n

M

SD

n

M

SD

1

11

1.09

.302

11

1.09

.302

2

11

1.64

.809

11

1.73

.786

3

11

2.18

.874

11

2.00

1.00

4

11

3.73

.786

11

2.55

1.036

5

11

3.55

1.214

11

3.00

1.265

6

11

2.91

.944

11

2.64

.809

7

11

3.00

.632

11

3.00

1.00

8

11

1.55

.820

11

2.64

1.286

9

11

3.73

1.009

11

3.73

1.191

10

11

3.64

1.286

11

3.45

1.368

11

11

2.91

1.221

11

3.64

1.206

12

11

3.73

1.272

11

3.27

1.348

Total

11

33.64

5.59

11

32.73

7.07
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The central null hypothesis of this research project was that the differences
between mean aggregate PSAS posts scores when compared with mean aggregate PSAS
pre scores would show a decrease in overall scores suggesting improved self-advocacy.
The alternative hypothesis was that post PSAS would be statistically superior. In
conducting a paired samples t-test of the difference between pre and post measures the
difference was not statistically significant, t (10) = .756, p = .467. We are unable to
reject the null hypothesis (See Figure 4-1 below).

Figure 4-1. Bar Chart Pre/Post PSAS Scores
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Central Hypothesis Number Two

It was hypothesized that the interval between time from confirming diagnosis of
MS and receiving the MS 101 instructional intervention would be inversely, and
statistically significantly related, to participant improvement scores in the PSAS measure.
To test this hypothesis, subtracting participant’s post PSAS measure from their pre PSAS
measure created a difference score (hereinafter called Pre/Post Change).
Table 4-10 shows grouping of participants based on the time elapsed between
confirmed diagnosis of MS and time of attending the MS 101 course. The majority of
participants (54.5%) had been diagnosed at least one month prior to the program, but no
more than 3 months prior. Two participants (18.2%) attended the program within the
first 30 days since being diagnosed. Two participants (18.2%) attended more than six
months after being diagnosed.

Table 4-10: Descriptive Statistics Interval from Discharge of Study
Participants
Frequency
Percent
< 1 Month
2
18.2
1-3 Months

6

54.5

3-6 Months

1

9.1

> Six Months

2

18.2

Total

11

100.0
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It is not reasonable to assume that time interval from diagnosis was normally
distributed so a Spearman’s Rank Order correlation was performed between interval and
the Pre/Post Change score.

Figure 4-2. Scatter Plot of Relationship between Interval and Pre/Post Change Score.
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As discerned from the correlation matrix in table 4-11, the Spearman Rho
correlation was positive in its direction (as opposed as negative as hypothesized),
however, this relationship was not statistically significant. We are therefore unable to
reject the null hypothesis that the impact of the instructional intervention was negatively
correlated with improvement in PSAS score.

Table 4-11: Spearman rho Correlation between Interval from Diagnosis
and Pre/Post Change Score
Interval From
Pre/Post Change Score
Dx
Interval from
1.00
.250
Dx
Sig. (2-tailed)
.229
N
11

Secondary Analysis
Table 4-12: Pearson Correlation between Pre Score Total and Age
Pre Score Total
Age
Pre Score Total
1.00
-.107
Sig. (2-tailed)
.754
N
11

Table 4-12 shows a Pearson Correlation between the total PSAS score from precourse and age. The Pearson Correlation was -.107 suggesting no correlation between
these items.
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Table 4-13: Spearman rho Correlation between Pre Score Total and
Education
Pre Score Total
Education
Pre Score Total
1.00
.061
Sig. (2-tailed)
.859
N
11
Table 4-13 compared pre-course PSAS scores with the amount of participant
education level. The Spearman’s rho correlation coefficient here was .061 showing no
significant correlation. In table 4-14 the Spearman rho correlation between post-course
PSAS totals of 0.187 showed no education level correlation.
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CHAPTER 5 – CONCLUSIONS AND RECOMMENDATIONS

Gallien et. a. (2014) discussed the importance of a collaborative approach to the
treatment of MS. The MS 101 courses provided in this report reinforced this by
presenting the multidisciplinary team and providing education about the role of each team
member. The collaborative approach was further promoted by the co-teaching of the MS
101 course by a registered nurse who specializes in the treatment of individuals with MS
and a licensed clinical social worker (LCSW) who is part of the MS team. One outcome
of Gallien’s research was the importance of educating patients on each provider’s role in
care to better facilitate the relationship between patients and each member of their care
team. As part of the information in the MS 101 course, the entire multidisciplinary team
was introduced to patients and their roles defined. Handouts were provided with pictures
and contact information of providers to assist with patient communication needs.
Multiple researchers including Bishop and Frain (2007, 2011), Fraser (2009) and
Holman (2004) have discussed the effectiveness of educational programs in management
and treatment compliance with progressive conditions. These researchers also noted that
patient education near the time of diagnosis is a critical component in assisting patients in
becoming active participants in their care and decision-making related to their care. The
work of these researchers coincides with the goals of this study, which were to identify
optimal timing for delivery of information given the known importance of education.
Bishop and Frain (2007, 2011) identified five components of MS-specific selfmanagement abilities. One of these components, treatment adherence and barriers was
assessed in PSAS item number 12 which determined how frequently patients were likely
to not comply with physician recommendations. Pre-course average scores were 3.73
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which decreased to 3.27. Although not a statistically significant change, it suggested a
trend that patients were likely to comply with physician’s recommendations. PSAS item
number 11 is also relevant to this question. Here, participants were asked how likely they
were to advocate for their beliefs or question their provider if they did not agree with
recommendations that were made. Pre-course averages of 2.91 increased to 3.64 postMS 101 courses. This trend suggests that following formal education, patients were more
likely to advocate for their beliefs or to question the provider when in doubt about the
care that was recommended. Although not a statistically different change, this trend
again suggests that patients may be more likely to advocate for themselves once educated
about their diagnosis.
Bishop & Frain’s work also addressed understanding and active learning about
medical conditions, which was also a part of this study. All participants voluntarily
elected to attend MS 101 with the goal of better understanding and learning more about
the condition. Two aspects that were not measured in this study was competency or
retention of the information presented. Further research should identify the patient’s
baseline knowledge of MS, and compare to post MS 101 knowledge and retention over
an extended time period. Formal assessment of pre/post understanding of MS would
ensure type and quantity of information that is gained from one course.
An additional component of Bishop & Frain’s (2007, 2011) work was the level of
active participation in decision-making. This was assessed in PSAS item number 5
which measured assertiveness when discussing care with providers. The average precourse score of 3.55 decreased to 3.0 following education. This trend implied that
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patients were more likely to be assertive after educational programming, a finding that is
supportive of research of Bishop and Frain.
The last component of Bishop & Frain’s (2007, 2011) five components of selfmanagement was how patients managed the impact MS has had on their life. Although
not objectively measured, this topic was covered in the MS 101 course. The LCSW
addressed disclosing the diagnosis to friends and family and issues with employment in
the MS 101 course. There were no specific measures obtained in this study to assess how
MS has impacted the lives of patients, offering an opportunity for future research.
Bishop et. al. (2009) identified that most patients sought information from was the
internet, books, physicians, support groups and MS societies. In this study, no patients
reported receiving any prior MS education, which implied that they may prefer this
course which was led by an MS-certified nurse and licensed clinical social worker who
practiced as a mental health therapist for patients with MS, which is in agreement with
Bishop’s work. However, additional questioning about previous independent education
about MS might be helpful to determine how much patients had read online or researched
on their own.
Somerset (2002) had reported previously that patients preferred to receive
education from MS-certified nurses. This study found that attendance at MS 101 courses
supported the idea that patients at Norton Healthcare also preferred to receive education
from MS-certified nurses. Patients had elected to attend this course and many had waited
a few months in order for this to be their primary means of education. Patients at Norton
Healthcare are informed about the MS 101 course by the neurologist or the Norton
Resource Center which sponsors the educational programs. Matti et. al. (2010) described
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the preference of patients for education from neurologists or specially trained staff
instead of primary care physicians or lay people.
Forbes et. al. (2007) described that patient needs for education are the greatest
early in the disease process. Most patients (73%) attended MS 101 within the first three
months since diagnosis, which aligned with Forbes’s recommendations. However, the
MS 101 course is only offered quarterly, which can limit the timeframe in which patients
can attend.
Box et. al (2003) evaluated the prevalence of patient education occurring within
the first year since diagnosis of MS, and reported an increase from 14% in 1974 to 72%
in 2000. This study aligned with the work of Box et. al. with 100% of the participants
obtaining formal education related to their condition within one year of a formal
diagnosis. In addition, the MS 101 course covered information about MS symptoms,
medication options, disease course and allowed for interaction with an MS certified
nurse. These were the most commonly reported areas of patient education need as by
Box (2003). However, in contrast to the work by Box, the MS 101 program had a
considerable amount of information regarding symptom management, which Box (2003)
had reported as being the biggest gap in patient education.
One of the major goals of this research was to establish the optimal timeframe in
which formal patient education should be completed for individuals newly diagnosed
with MS to optimize their ability to self-advocate. This goal was supported by the work
of Chiovetti (2006) who reported on the critical need for patient education to occur at an
appropriate time and at the appropriate levels. However, we were unable to identify what
the critical timeframe is for this patient population. In addition, without retention tests,
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we cannot speak to the amount of information that was provided in the MS 101
programming. Chiovetti (2006) also described the importance of health literacy and
ensuring all patient education materials were written to a level that all patients could
understand. Although there was no formal assessment of this, MS 101 course organizers
reported that course materials were developed at a third grade reading level.
Chiovetti (2006) has documented that formal patient education should occur in a
friendly environment. The MS 101 course took place in a large conference room with
space available for snacks and breaks as needed. The room was setup to promote
discussion and involvement of all participants. An additional recommendation made by
Chiovetti was for materials to be provided in written and verbal forms, through the use of
Powerpoint and printed handouts.
Broadbent et. al. (2006) found that women with MS had higher reported selfmanagement skills than men, a result was not found to be significant in this study.
Broadbent et. al. (2006) and Wilski and Tasiemski (2015) each reported that individuals
with higher education levels scored higher on self-management questionnaires. This
study did not find a correlation between education levels and PSAS scores. (See Table 413).
Key Findings
A major hypothesis of this study was that time since diagnosis of MS and patient
reported self-advocacy would be correlated. We hypothesized that there would be an
ideal timeframe in which patient education should be provided to maximize selfadvocacy. The findings of this study did not support these hypotheses. However, there
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were some important trends that were noted that offer insight to the value of this
educational program and highlight further needs for education and research in this area.
PSAS item number 2 explores the likelihood of a patient seeking out information
on the diagnosis. The mean score increased from 1.64 pre-course to 1.72 post-course.
Although this change was not statistically significant, it suggested that patients may be
less likely to seek out additional information, which may indicate the MS 110 course
made he feel they were adequately informed about their diagnosis at that time.
PSAS item number 3 decreased from 2.18 to 2.00 between pre and post-course
surveys. This item assessed if patients felt they were more educated than the typical US
citizen about their own health. A decrease of 0.18 was not statistically significant but
suggested patients believed their education level had improved and provided additional
support of the value of patient education.
One of the more meaningful changes reported here was PSAS item number 4 that
decreased from 3.73 to 2.55 for an overall change of 1.18. This change suggested that
patients understood their condition better following formal education. A better
understanding of the condition following patient education might imply the importance of
offering educational programs early in the disease process.
Item number 11 was also an importance factor in this study as it assessed how
likely patients were to advocate for beliefs after receiving formal education. A decrease
in PSAS scores from 3.64 to 3.45 was not statistically significant but again suggests that
educational programs increased self-advocacy and empowered patients to act on their
own behalf in regards to medical care.
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The last PSAS item that supported this hypothesis was number 12 which
determined how likely patients were to not comply with physician recommendations. A
decrease in mean scores from 3.73 to 3.27 was noted here which indicated that patients
were more likely to be compliant. This suggested that education offered insight into the
condition, treatment options and was likely to promote patient compliance.
An addition major hypothesis of this study was that patient educational attainment
and reported self-advocacy would be correlated. Individual education level was
compared with the change in PSAS scores; the Spearman rho correlation was .061
showing no correlation between patient formal education and PSAS scores.
Another hypothesis of this study was that the amount of education provided could
impact self-advocacy scores. This data was not objectively collected in hopes of patients
using feedback forms or discussion to offer insight in this area. However, patients did
not provide any meaningful feedback as to the length of the program or content that
offered strong recommendations into potential program modification.
This research suggests the importance of patient education and the need to ensure
timely delivery of education to maximize self-advocacy. The trend in averages between
pre and post-course PSAS scores suggests that patient education was successful in
allowing patients to better understand their diagnosis and various treatment options
related to their condition. Another important trend in scores was increased likeliness of
seeking out information related to their condition, which suggests that patients had a
better understanding on how to seek out information and about resources available to
them. PSAS item number 8 showed that after the MS 101 course individuals were less
likely to question physicians when they did not agree with a recommendation. This
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suggests that patients have improved trust in their healthcare team following education
provided by members of the comprehensive MS team. PSAS item 10 showed a trend
towards individuals feeling that they had better awareness of their needs following and
MS 101 program. PSAS item number 11 showed a trend towards patients reporting that
they were more likely to advocate for their healthcare needs following an educational
program. All of these trends support the value of patient education and the need for
patient education to be readily available to patients. This information is valuable to the
funding sources that support programs such as MS 101 in continuing to provide this
programming to maximize patient potential. An additional value of the MS 101 program
is the experience itself where individuals are able to interact with others with their
condition and develop a bond with healthcare providers to help them feel more supported.

Limitations of the Study
There were several limitations to this study, the most prominent of which was the
small number of participants resulting in low power for statistical analysis. The total
enrollment for the study was 11 participants. Every individual approached about the
study agreed to participate, so none were excluded. One potential reason for low
enrollment was the relatively short duration of data collection, which spanned over a nine
month period but with only three offerings. In addition to the limited course offerings,
the timing of the courses may not have been reasonable for patients who work as the
general timeframe was 1pm-5pm on a weekday.
Another limitation of this study was it only evaluated the immediate impact of the
educational program without long-term follow-up to assess the program effectiveness on
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patient self-advocacy or educational needs which would be essential to assess the
cognitive load theory implications on retention of large amounts of information. In
future studies, a baseline evaluation of individual’s knowledge of MS prior to the MS 101
courses should be used and compared to post-test values to assess program material
comprehension. Further research should also include an assessment of knowledge
retention. According to the cognitive load theory, learners can become overwhelmed
when trying to process and transfer large amounts of information from working memory
to long term memory. An immediate post-test and a retention test would allow
researchers to evaluate components of cognitive load theory specific to this patient
population.
This study evaluated only one educational program at one comprehensive MS
center, providing limited ability to apply to other such programs and threatening external
validity. Other centers that use different strategies for patient education may not be able
to generalize the findings of this study to standardize educational procedures.
Factors affecting internal validity were also present in this study. There was no
baseline assessment done to evaluate prior knowledge of MS. Patient intake forms
assessed prior MS education with no patients reporting previous understanding or
knowledge. However, it is likely that some patients had sought to educate themselves
about the diagnosis through other means. There is also the potential that some patients
could have a medical background and/or have previous knowledge of MS through friends
or relatives with the same diagnosis.
An additional threat to internal validity was the potential for psychological
changes within the patient during the study. Although pre and post measures were
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collected on the same day, there may have been experiences during the course that could
have affected patient-reported outcomes. For example, some patients may have been
motivated or discouraged by hearing about other people’s experiences, which could have
impacted their self-advocacy scores.
The testing component could have some impact on study validity as well. The
same measure (PSAS) was used as a pre-test and post-test, but the potential for fatigue
exists. Patients may have become fatigued during the four-hour course or had external
factors that caused them to answer quickly or put less effort into their responses in an
effort to complete the study and leave sooner.
This study lacked randomization; a sample of convenience was used based on
patients who had elected to attend the MS 101 courses that occurred during the data
collection period. All patients were given the option to participate after consent was
given and educated about the role of the researcher. There is a possibility that patients
felt obligated to agree to participate since they were approached directly by the
researcher, who was also identified as a member of the MS treatment team. Patients may
have perceived this situation as pressure to participate, although during the consent
process, they were assured that participation was voluntary and confidential.
A potential impact on applicability of this study is that only the MS 101 course at
Norton Healthcare was evaluated, which limits the generalizability of the findings to only
this educational program. The current model for patient education at Norton Healthcare
for other progressive neurologic conditions such as Parkinson’s disease is similar to MS
101. Other MS centers have varying methods of patient education – most centers provide
education online, and some centers provide shared medical appointments where patients
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interact in small groups with a provider to be educated on their diagnosis. There is
limited research supporting the efficacy of these types of educational programs.

Recommendations for future research
As a result of this research study, many suggestions for future research can be
made. This research did not specifically look at the length of the MS 101 course and the
potential implications of the cognitive load theory. Previous researchers hypothesized
that an educational program that is too long or that provides too much information may
affect the learner’s ability to comprehend or retain the material. Some means of
evaluating and making recommendations for the ideal length of educational programs
would be useful in planning future programming and optimizing the information
provided to patients. Cognitive load theory refers to an individual’s ability to absorb new
information and recognize individual differences, but a large study could make some
general recommendations in regards to program length. Ideally, a comparative study that
collects feedback from two MS 101 programs, one of shorter length and one more
comprehensive and then evaluates comprehension, retention and patient feedback on the
volume of information would be helpful. That data should be compared with post-course
comprehension and retention scores to objectively document differences.
Future studies in this area should also consider a baseline cognitive assessment,
specifically when interested in the cognitive load theory or retention of education.
Depending on the size and location of MS lesions, memory and cognitive function could
be impaired even within the first year of diagnosis, which would impact an individual’s
ability to comprehend and retain information provided in MS 101 courses and could
further impact their PSAS scores. Additionally, patients that have difficulty
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understanding or retaining information may become frustrated with the program and this
could impact PSAS scoring. One method to assess this would be to provide a baseline
cognitive assessment and evaluate for any correlation between scores on these
assessments and self-reported PSAS scores.
Additionally, supplementary subjective feedback from patients on the content,
length and presenters of the program should be gathered. A general course review was
provided but patient comments were not a part of that review.
This study assessed only one center’s approach to educating patients that are
newly diagnosed with MS. In future studies, a comparative analysis that studies at
different models would be helpful. This could lead to standardized formal education
programs and provide a framework for newer MS programs on optimal formatting for
patient education.
A significant portion of the MS 101 course addressed the impact of MS on the
lpatients’ lives, disclosure of the diagnosis to family and friends, and future barriers,
including coping skills, anxiety, depression, missed work and disability. However, there
was no objective measure such as a quality of life tool taken during this study to assess
how MS had impacted the lives of the patients that participated. In future research, this
would be a valuable tool to track the impact at the time of diagnosis and as the disease
progresses.

One major goal of this study was to examine the MS 101 program and determine
the relationship between time since diagnosis and perceived self-advocacy and
recommend an ideal timeframe in which patient education should be initiated and
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completed. Future studies may consider motivation as a correlate between attendance
and self-advocacy. Patients may have attended programs based on their own interest or
goals or attended at the request of family members. Patient motivation and self-advocacy
may indeed be related.
A significant component of the self-advocacy questionnaire involves patient
interactions with physicians and willingness to ask questions and interact with providers.
Future research should consider previous interactions with physicians as a possible factor
in self-advocacy. Patients may have seen multiple providers through the diagnostic
process or had other encounters with healthcare professionals that played a critical role in
self-reported PSAS scores. For example, a negative interaction with a past provider may
influence patients’ ability to advocate for needs and this factor should be considered in
further research.
An additional factor that should be considered is the level of family support.
Many patients attending MS 101 were accompanied by spouses, parents or other family
members, but this data was not formally collected. In future studies, this may be a
critical factor to consider. Some individuals may rely heavily on family members during
medical appointments, which could impact their reported self-advocacy measures. In
other cases, family may be less involved and place more demands on the individual to
manage their own medical needs. This factor may become especially important in
individuals with cognitive impairments.
In this research, no specific information was collected about each individual’s
disease, such as the type of MS (if known), number of lesions, relapses, responses to
medications or aggressiveness of their disease. One standardized tool for assessing the
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level of impairment in MS is the Expanded Disability Status Scale (EDSS) which
evaluates the level of function specific to mobility. Obtaining this information would
require access to medical records and physician documentation, but may offer an
interesting area of research to determine if there are correlations between the level of
disability and patient-reports self-advocacy.
Finally, another area for future research is long-term follow-up to determine is
self-advocacy at diagnosis translated into improved outcomes or improved disease
management. For this research to be completed there would need to be a lengthy study
following patients over several years, which could present challenges with research
personnel and the ability to monitor patients for prolonged periods of time.
Researcher Observations
There were several observations made by the researchers during this study that
warrant discussion. Although MS 101 is presented by a nurse and social worker, which
supports the multidisciplinary approach, there would likely be great value in a brief
discussion with a patient who has lived with MS for some time. This would allow newly
diagnosed individuals to learn from the experience of others they may relate better to.
This would also allow for individuals to possibly ask questions from someone they view
as a peer that they may not necessarily bring up with medical professionals.
Additionally, this opportunity would likely generate some personal relationships that
could be beneficial to individuals as they cope with their diagnosis.
In recommendations to Norton Healthcare, it was suggested that the MS 101
course be decreased to three hours with challenging topics such as coping and disability
being removed. Through observation, I found that these difficult discussions changed the
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energy of the course, resulted in some individuals withdrawing from discussion and
becoming more emotional. Since this suggestion was made, the program has been
modified and the abbreviated MS 101 course begins in February 2017. Additionally, I
suggested an optional MS 102 course that could run once or twice per year specifically to
address issues with disclosure, employment or disability. I also suggested that providers
strive to limit their referrals to MS 101 programs to those individuals diagnosed within
one-year timeframes. In one observation, I noted a patient with a more aggressive form
of MS who had been diagnosed for several years attending the program and noted some
changes in discussion that could be viewed as intimidating to newly diagnosed
individuals.
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